Biomarin Pharmaceutical Inc (BMRN) — Strategic Asset Allocation Index
Biomarin Pharmaceutical Inc (BMRN) has a Strategic Asset Allocation Index of 0.0% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $6.32 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BMRN net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Biomarin Pharmaceutical Inc Strategic Asset Allocation Index (2000–2025)
This chart shows how Biomarin Pharmaceutical Inc's Strategic Asset Allocation Index has evolved across 24 annual periods from 2000 to 2025. As of June 2026, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $6.32 Billion USD. For live market cap and overall valuation, see Biomarin Pharmaceutical Inc (BMRN) market capitalisation.
Annual Strategic Asset Allocation Index for Biomarin Pharmaceutical Inc (2000–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Biomarin Pharmaceutical Inc from 2000 to 2025, covering 24 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Biomarin Pharmaceutical Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 8.1% | $492.24 Million | $- | $492.24 Million | $6.09 Billion | ▼ -1.1 pp |
| 2024 | 9.2% | $521.24 Million | $- | $521.24 Million | $5.66 Billion | ▼ -3.1 pp |
| 2023 | 12.3% | $611.13 Million | $- | $611.13 Million | $4.95 Billion | ▼ -19.1 pp |
| 2022 | 31.5% | $1.45 Billion | $1.11 Billion | $333.83 Million | $4.60 Billion | ▼ -4.7 pp |
| 2021 | 36.1% | $1.54 Billion | $1.04 Billion | $507.79 Million | $4.27 Billion | ▲ +4.0 pp |
| 2020 | 32.1% | $1.32 Billion | $1.03 Billion | $285.47 Million | $4.11 Billion | ▼ -13.5 pp |
| 2019 | 45.6% | $1.42 Billion | $1.01 Billion | $411.98 Million | $3.12 Billion | ▲ +5.7 pp |
| 2018 | 39.9% | $1.18 Billion | $948.68 Million | $235.86 Million | $2.97 Billion | ▼ -5.8 pp |
| 2017 | 45.7% | $1.28 Billion | $896.70 Million | $385.79 Million | $2.81 Billion | ▼ -3.9 pp |
| 2016 | 49.6% | $1.37 Billion | $798.77 Million | $572.71 Million | $2.77 Billion | ▲ +1.8 pp |
| 2015 | 47.8% | $1.15 Billion | $704.21 Million | $443.71 Million | $2.40 Billion | ▲ +7.1 pp |
| 2014 | 40.7% | $622.41 Million | $523.52 Million | $98.89 Million | $1.53 Billion | ▼ -3.1 pp |
| 2013 | 43.8% | $587.83 Million | $319.32 Million | $268.52 Million | $1.34 Billion | ▲ +4.3 pp |
| 2012 | 39.5% | $401.55 Million | $284.47 Million | $117.07 Million | $1.02 Billion | ▼ -7.5 pp |
| 2011 | 47.1% | $363.92 Million | $268.97 Million | $94.94 Million | $773.05 Million | ▼ -1.9 pp |
| 2010 | 49.0% | $351.12 Million | $221.87 Million | $129.25 Million | $717.26 Million | ▼ -12.9 pp |
| 2009 | 61.8% | $199.14 Million | $199.14 Million | $- | $322.19 Million | ▲ +16.6 pp |
| 2008 | 45.2% | $124.98 Million | $124.98 Million | $- | $276.68 Million | ▲ +4.3 pp |
| 2007 | 40.9% | $76.82 Million | $76.82 Million | $- | $187.73 Million | ▼ -6.2 pp |
| 2006 | 47.1% | $55.47 Million | $55.47 Million | $- | $117.80 Million | ▲ +25.7 pp |
| 2003 | 21.3% | $25.15 Million | $25.15 Million | $- | $117.85 Million | ▼ -7.3 pp |
| 2002 | 28.6% | $28.21 Million | $28.21 Million | $- | $98.54 Million | ▲ +8.2 pp |
| 2001 | 20.4% | $32.56 Million | $32.56 Million | $- | $159.55 Million | ▼ -9.2 pp |
| 2000 | 29.6% | $20.71 Million | $20.71 Million | $- | $69.99 Million | — |